KPV: Benefits, side effects, dosage details, and how it works

The word “inflammation” crops up a lot in health discussions, and that’s for good reason. Left unchecked, inflammation becomes a chronic health problem that spells serious trouble for your tissues and organs, immune function, and overall health. But inflammation stems from numerous possible causes, not all of which are under your control.

There’s a peptide, however, that might be able to police your body’s inflammatory response when you can’t. It’s called KPV.

In this guide, we explain how the KPV peptide works, break down the research into its effects, and discuss its availability to healthcare consumers.

Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles.

Our series on therapeutic peptides has taken us through articles on hundreds of clinical studies and other scientific sources on the subject, spread over more than 1,000 cumulative hours. KPV alone involved several dozen such sources and upwards of 30 hours. Along the way, we leaned on our relationships with people who know peptides on the ground level — both prescribers and patients. Although KPV isn’t an FDA-approved drug with widespread human use, these practical perspectives have allowed us to deduce its relative position in the larger peptide landscape.

Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy and will continue to be monitored for updates by our editorial team.

KPV is a therapeutic tripeptide consisting of the amino acids lysine, proline, and valine (whose scientific abbreviations — K, P, and V — make up its name). Specifically, KPV is a fragment of alpha-melanocyte-stimulating hormone (α-MSH), a larger peptide with anti-inflammatory, antimicrobial, and fever-reducing properties.1 Even more specifically, the fragment in question is the C-terminal region of α-MSH, which is particularly good at neutralizing pathogens.2

While many therapeutic peptides are taken by needle, KPV stands apart in that it can also be administered as an oral capsule or chewable tablet. Its ability to be delivered through multiple routes may stem from a possible affinity for a peptide transporter, hPepT1, that occurs in the gastrointestinal tract.3 Researchers have also administered KPV topically or transdermally through technologies such as ionophoresis, which uses small electrical currents to drive the medication through the skin.4 There are even battery-integrated patches that use this technology.5 That being said, subcutaneous injection is likely the most rapid form of KPV drug delivery for systemic benefits.

KPV’s principal therapeutic value lies in its anti-inflammatory action. As your body’s natural response to harm from injury or illness, inflammation is essential for initiating the healing process. But when inflammation is severe or chronic, it becomes excessive and damages the body it’s meant to protect.6 Unless you get it back under control, it can contribute to serious health complications down the line — cardiovascular diseases, chronic obstructive pulmonary disease, cancer, and Alzheimer’s, to name a few.7 KPV’s role as a treatment is to prevent those complications from arising or worsening.

In addition, with its origins in α-MSH, KPV has demonstrated therapeutic value related to immune function, namely antimicrobial and wound-healing potential.

Of note, the research on KPV’s effects has been done primarily in animal models and human cell cultures, not in human subjects directly. Therefore, the support for its therapeutic uses is limited, albeit largely optimistic. Below, we discuss some of the most promising findings to date.

The scientific literature says little about KPV’s safety profile, but there are concerns that it carries significant potential risks. From researchers, the most direct proclamation on the subject is found in the previously referenced 2017 mouse study, which described KPV as a “naturally derived tripeptide without any notable side effects,”11 but a weightier opinion given by the U.S. Food & Drug Administration (FDA) casts doubt on the study’s claim:

“FDA has not identified any human exposure data on drug products containing KPV administered via any route of administration. FDA lacks important information regarding any safety issues raised by KPV, including whether it would cause harm if administered to humans.”18

In other words, there have been no dedicated safety studies on KPV, so its status as a safe or unsafe therapy is up in the air. But notably, the FDA made this statement in a release about bulk drug substances (ingredients used to make medicines) that it considers to pose “potential significant safety risks,” so KPV’s lack of safety studies is a red flag in that regard.

Apart from its unclear safety profile, we can presume, based on our dealings with prescribers, that KPV administered subcutaneously can cause certain side effects that are common to most therapeutic peptide injectables: injection site reactions and mild, transient flu-like symptoms. We also know that certain populations — pregnant or breastfeeding women and people with a history of cancer — are contraindicated for peptide use.

Research-grade vs. pharmaceutical-grade KPV

Pharmaceutical-grade drugs meet high chemical purity standards and have been approved or indexed by the FDA as being fit for human consumption. Research-grade drugs do not meet such standards and so are intended for laboratory use only.

KPV is not an FDA-approved drug, so practically all commercially available KPV through an online vendor will undoubtedly be research-grade material that is not fit for human consumption. If consumed, its relatively high level of impurities will elevate the risk of immunogenicity (a state in which the body’s immune system interprets a substance as a danger and mounts a potentially life-threatening response against it).19

You might be able to get a prescription for pharmaceutical-grade KPV from a clinician, but you’ll first have to meet specific conditions. We discuss the matter further under “Where to find KPV” at the end of this guide.

No standard treatment protocol has yet been established for KPV, as it isn’t FDA-approved and few to no human trials have been conducted with it. The relatively scant number of reputable clinics that prescribe it may each have their own protocol that can’t be neatly homogenized here in summary. We can, however, deduce what the protocol is likely to be based on our findings in the existing literature, our familiarity with peptides in general, and the knowledge we’ve gained through relationships with prescribers and users of other therapeutic peptides:

We normally include information about a peptide’s timeline of benefits, but to do the same with KPV would require an unreasonable amount of unhelpful conjecture. We could say, for example, that KPV’s antimicrobial benefits take effect within two hours (as in the study from 2000),15 but in real-world use, the treatment itself would take place across a longer timeline whose exact length can vary from person to person, case to case.

Meanwhile, the user wouldn’t notice KPV’s benefits in the same way they would with a weight-loss or focus peptide, because its effects don’t manifest so visibly. At most, one might eventually acknowledge that they feel better compared to an earlier state, but that isn’t like seeing a lower weight on the bathroom scale or noticing increases in sustained cognitive effort. The only measurable data related to KPV’s benefits are inflammatory biomarkers, microbial counts, and wound sizes, but the average user probably doesn’t have the means or interest to record those.

In a world where KPV is a widely available prescription, the prime candidates for its use would be people with chronic inflammation, persistent bacterial or fungal infections, or stubborn wounds. Within these populations are people with risk factors that might make them better candidates than others, such as:

• Stress: Chronic stress not only promotes an inflammatory state but also can prolong bacterial infections and discourage wound closure.7 21 22
• Overweight or obesity: People with excess weight are also at risk for chronic inflammation, persistent infections, and slower wound healing. That’s because having a higher proportion of body fat correlates with the release of more pro-inflammatory cytokines, an attendant decrease in immune function, and potentially increased wound tension from underlying adipose tissue, among other things.7 23 22
• Age: Older people tend to have more inflammatory molecules, possibly stemming from elevated levels of reactive oxygen species, which in turn can prolong wound-healing time.24 They’re also likely to have weakened immune systems, which reduces the ability to fight off infections as well as to heal wounds.25

Other risk factors also contribute to the health conditions that KPV can help treat (e.g., poor nutrition, poor sleep, and smoking), but they’re more feasibly reversible with other interventions. That’s to say that a person would do better to fix their diet, take supplements to sleep better, and quit smoking than to take KPV to address the downstream effects of their lifestyle.

Additionally, like other therapeutic peptides, KPV is likely contraindicated for pregnant or breastfeeding women and people with a history of cancer.

More than a few online vendors offer KPV, but it’s highly unlikely that it’s a genuine pharmaceutical-grade peptide. What they’re really selling, probably, is research-grade material and just passing it off as pharma-grade. Remember, research-grade peptides are not suitable for human consumption, so taking stuff you bought online could lead to life-threatening circumstances.

Currently, as KPV remains on the FDA’s Category 2 list of restricted drugs, the only way to get the real deal is by qualifying for an exemption from the Federal Food, Drug, and Cosmetic Act.26 To do that, you have to meet at least two criteria:27

• You must have a prescription for KPV from a licensed clinician
• You must need KPV to treat your health condition, as no other drug can safely or effectively treat it

Your chances of fulfilling these criteria depend on your doctor’s willingness to have you try what’s effectively an experimental drug. To that end, there are reputable clinics in the United States that prescribe KPV and other restricted peptides, though they typically don’t deal in telemed or ship their treatments.

The FDA’s opinion on restricted peptides, not to mention the laws surrounding them, is subject to change. As more research is done, KPV may become more widely available. If that happens, we’ll update this guide accordingly and point you to the best pathways to prescription access.